Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Justin E. Bekelman, MD

Justin E. Bekelman, MD Physician

Associate Professor of Medical Ethics and Health Policy Associate Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

Dr. Bekelman is employed by Penn Medicine.

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Patient Comments

Clinical Specialties


  • Radiation Oncology

Programs & Centers:

Board Certification:

  • Radiation Oncology, 2009

Clinical Expertise:

  • Bladder Cancer
  • Kidney Cancer
  • Penile Cancer
  • Prostate Cancer
  • Proton Therapy
  • Radiation Oncology - Genitourinary
  • Radiation Treatment
  • Testicular Cancer
  • Urethral Cancer

Description of Clinical Expertise

Dr. Bekelman is a radiation oncologist who specializes in the early detection, surveillance and treatment of prostate cancer. Our clinical team has developed radiation therapy techniques to preserve urinary, bowel and sexual function after treatment. We work with clinical experts from urology, medical oncology, radiology, pathology, and advanced practice nursing to improve cancer control, outcomes, and quality of life for our patients. Dr. Bekelman also has expertise in the treatment of testicular and bladder cancer.

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Amerihealth
  • NJ Medicaid
  • NJ Medicare
  • NJ Qualcare
  • Oxford Health Plan
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan

Education and Training

Medical School: Yale University
Residency: Johns Hopkins Hospital
Residency: Memorial Sloan-Kettering Cancer Center


American Society for Radiation Oncology (ASTRO), National American Society of Clinical Oncology (ASCO), National Centers for Medicare & Medicaid Services, National Massachusetts General Hospital and MD Andersen Cancer Center, 2 U19 CA021239-35, National Radiation Oncology Institute, National

Hospital Affiliation

Dr. Bekelman is employed by Penn Medicine.

Hospital Privileges:

  • Chester County Hospital: Has privileges to treat patients in the hospital.
  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Justin E. Bekelman, M.D., is Associate Professor in the Departments of Radiation Oncology and Medical Ethics and Health Policy at the Perelman School of Medicine, Faculty in the Center for Health Incentives and Behavioral Economics, and Senior Fellow at the Penn Center for Precision Medicine and the Leonard Davis Institute for Health Economics, all at the University of Pennsylvania. Dr. Bekelman leads research programs in cancer comparative effectiveness and delivery system and payment reform, integrating methods from the fields of epidemiology, clinical trials, health economics and public policy. In his delivery system and payment reform research, Dr. Bekelman leads studies to evaluate the impact of financial and non-financial strategies to improve the quality, outcomes and affordability of cancer treatments and reduce unnecessary variation in clinical practice. In his comparative effectiveness research, Dr. Bekelman leads Patient-Centered Outcomes Research Institute (PCORI) and National Cancer Institute (NCI) funded pragmatic and efficacy randomized clinical trials of proton and photon therapy for breast and prostate cancer. Dr. Bekelman's research has appeared in scientific journals such as the Journal of the American Medical Association and the Journal of Clinical Oncology and has been featured in the mainstream media, including the New York Times, the Wall Street Journal, National Public Radio, and news outlets in Canada, Latin America, and Europe. He has received research funding from the National Cancer Institute, the Patient-Centered Outcomes Research Institute, the American Cancer Society, and philanthropic sources.

Dr. Bekelman completed his undergraduate studies at Princeton University in the Woodrow Wilson School of Public and International Affairs and his medical training at Yale University, Johns Hopkins, and Memorial Sloan Kettering Cancer Center. Previously, he was a management consultant at the Kalchas Group, advising senior executives of health care and insurance clients on corporate strategy. Dr. Bekelman also served as Special Assistant to the Under Secretary of Defense in the US Department of Defense. He is a board-certified radiation oncologist and practicing physician at the University of Pennsylvania Perelman School of Medicine.

Selected Publications:

Yasaitis L, Polsky D*: Relation between Narrow Networks and Providers of Cancer Care Journal of Clinical Oncology : 2017.

6 Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer Int J Radiat Oncol Biol Phys 97 (4): 718-721,2017.

Ojerholm E, Halpern SD: Default options: opportunities to improve quality and value in oncology Journal of Clinical Oncology 34 (16): 1844-7,2016.

Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H: Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries JAMA 315 (3): 272-283,2016.

Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D: Effectiveness of Androgen Deprivation Therapy and Radiotherapy for Older Men with Locally Advanced Prostate Cancer Journal of Clinical Oncology 33 (7): 716-22,2015.

Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N: Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer JAMA Oncology 1 (7): 897-906,2015.

Bekelman JE, Sylwestrzak G, Barron J, Liu J, Epstein AJ, Freedman G, Malin J: Uptake and Costs of Hypofractionated vs. Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008 - 2013 JAMA 312 (23): 2542-50,2014.

Bekelman JE, Kim M: Toward Accountable Cancer Care JAMA Internal Medicine 173 (11): 958-9,2013.

Bekelman JE, Epstein AJ: Single vs Multiple Fraction Radiotherapy for Bone Metastases from Prostate Cancer JAMA 310 (14): 1501-02,2013.

View all publications

Academic Contact Info

Department of Radiation Oncology
Abramson Cancer Center
Perelman School of Medicine
University of Pennsylvania
3400 Civic Center Boulevard

Philadelphia, PA 19104
Phone: (215) 662-7266
Patient appointments: 800-789-7366 (PENN)

Related Links